Toggle menu

SALI Study

Start date:
August 2016
End date:
31 October 2017
Co-ordinated by:
Julia Grahamslaw
Main trial site:
Royal Infirmary of Edinburgh


This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Trial Design

Longitudinal prospective cohort questionnaire study

Eligibility criteria

Patients of 18 yrs and older, with isolated ankle injuries, who meet the Ottawa Ankle Rules positive (OAR+) criteria (Buffalo modification), but are negative for a significant ankle fracture on subsequent x-ray, will be included in the study.

Local PI

Professor Alasdair Gray

Director of EMERGE & Consultant in Emergency Medicine

Research Team

Julia Grahamslaw

Lead Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

Emma Ward

Research Administrator

Hedda Nyhus

Senior Research Nurse

Adam Lloyd

PhD Student & Senior Research Nurse

Allan MacRaild

Senior Research Nurse

Megan McGrath

Senior Research Nurse

Bernadette Gallagher

Senior Research Nurse

Bev Goldberg

AMU Senior Research Nurse

Mia Paderanga

Senior Research Nurse

Alison Grant

Senior Research Nurse

More EMERGE Trials

Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world

Read more


Global Anticoagulant Registry In the FIELD – Venous Thromboembolic Events

Patients commonly present to the Emergency Department with epistaxsis (nose bleed). Standard first aid measures such as applying pressure can often stem bleeding however in more severe cases of epistaxsis further treatment is required.

Read more


Novel Use of Tranexamic Acid to Reduce the Need for Nasal Packing

The study with PP100-01 in combination with NAC is designed to determine safety and tolerability of PP100-01 when co-administered with NAC as compared to the 12-hr NAC treatment regime for patients that come to the hospital after an overdose of paracetamol/acetaminophen.

Read more

The POP Trial

A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose